- Investing Ideas
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
1 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Chugai Pharmaceutical
Market Cap: JP¥14.1t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,387.00
7D
-3.3%
1Y
0.7%
Daiichi Sankyo Company
Market Cap: JP¥5.3t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,936.50
7D
5.9%
1Y
-8.6%
Takeda Pharmaceutical
Market Cap: JP¥8.9t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
New
4502
JP¥5,608.00
7D
-2.2%
1Y
30.8%